Education
About Us
Working with TipRanks
Follow Us
Clinuvel Pharmaceuticals Limited (AU:CUV)
ASX:CUV
CUV Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CUV Stock 12 Month Forecast
There Are No Analyst Ratings for AU:CUV In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
CUV Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Morgans
AU$14
Buy
26.35%
Upside
Upgraded
11/11/25
Canaccord Genuity
AU$32.84
Buy
196.39%
Upside
Reiterated
10/03/25
Bell Potter
AU$19
Buy
71.48%
Upside
Reiterated
08/29/25
Jefferies
AU$40
Buy
261.01%
Upside
Reiterated
07/18/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgans
AU$14
Buy
26.35%
Upside
Upgraded
11/11/25
Canaccord Genuity
AU$32.84
Buy
196.39%
Upside
Reiterated
10/03/25
Bell Potter
AU$19
Buy
71.48%
Upside
Reiterated
08/29/25
Jefferies
AU$40
Buy
261.01%
Upside
Reiterated
07/18/25
Best Analysts Covering Clinuvel Pharmaceuticals
3 Months
xxx
Success Rate
1/2 ratings generated profit
Average Return
+1.70%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.70% per trade.
1 Year
Success Rate
1/2 ratings generated profit
Average Return
+3.20%
reiterated a buy rating 4 months ago
Copying OpenAI Biotechnology's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.20% per trade.
2 Years
xxx
Success Rate
1/2 ratings generated profit
Average Return
+3.20%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +3.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CUV Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
9
11
36
42
40
Buy
2
0
0
0
0
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
12
37
43
40
Each month's total comprises the sum of three months' worth of ratings.
CUV Stock Forecast FAQ
What is AU:CUV’s average 12-month price target, according to analysts?
Currently, no data Available
What is AU:CUV’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AU:CUV, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Clinuvel Pharmaceuticals Limited a Buy, Sell or Hold?
Currently, no data Available
What is Clinuvel Pharmaceuticals Limited’s share price target?
Currently, no data Available
What do analysts say about Clinuvel Pharmaceuticals Limited?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Clinuvel Pharmaceuticals Limited?
To buy shares of AU:CUV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.